Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Verona
Pharma
FDA signs off on Regeneron and Sanofi's Dupixent for COPD
The FDA has expanded the label of Regeneron and Sanofi's Dupixent to treat COPD. Dupixent becomes the first biologic for COPD patients in the U.S.
Kevin Dunleavy
Sep 27, 2024 9:40am
Verona's price for COPD drug far exceeds ICER's valuation
Jul 16, 2024 2:31pm
EU signs off on Regeneron and Sanofi's Dupixent for COPD
Jul 3, 2024 10:05am
Verona earns FDA nod for potential blockbuster to treat COPD
Jun 26, 2024 6:26pm
FDA delays decision on Sanofi and Regeneron's Dupixent for COPD
May 31, 2024 9:30am
GlobalData, ICER weigh in on Verona's COPD drug ensifentrine
May 30, 2024 12:17pm
